[ Price : $8.95]
Federal Register notice: FDA issues an order debarring David Elias Mendoza for five years from importing or offering for import an...[ Price : $8.95]
Protalix BioTherapeutics and Chiesi Global Rare Diseases resubmit a BLA for PRX102 (pegunigalsidase alfa) for treating adult patie...[ Price : $8.95]
Roche says results from two Phase 3 studies evaluating Alzheimers therapy gantenerumab were not statistically significant in slowi...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Referencing the Definition of a Device in the Federal Food,...[ Price : $8.95]
Federal Register notice: FDA determines for patent term extension purposes the regulatory review period for Mercks Prevymis (leter...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Q5A(R2) Viral Safety Evaluation of Biotechnology Products D...[ Price : $8.95]
Satsuma Pharmaceuticals says topline results from the STS101 SUMMIT Phase 3 efficacy trial showed numerical differences in favor o...[ Price : $8.95]
FDA grants ImmunoGen an accelerated approval for Elahere (mirvetuximab soravtansine-gynx) for treating certain adult patients with...